nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Sibutramine—obesity	0.112	0.27	CbGbCtD
Conivaptan—CYP3A4—Benzphetamine—obesity	0.0849	0.204	CbGbCtD
Conivaptan—CYP3A4—Bupropion—obesity	0.0722	0.174	CbGbCtD
Conivaptan—CYP3A4—Orlistat—obesity	0.0588	0.142	CbGbCtD
Conivaptan—CYP3A4—Cimetidine—obesity	0.053	0.127	CbGbCtD
Conivaptan—CYP3A4—Topiramate—obesity	0.0347	0.0834	CbGbCtD
Conivaptan—AVPR1A—respiratory system—obesity	0.00961	0.238	CbGeAlD
Conivaptan—AVPR2—respiratory system—obesity	0.00796	0.197	CbGeAlD
Conivaptan—AVPR1A—adrenal gland—obesity	0.00582	0.144	CbGeAlD
Conivaptan—AVPR2—adipose tissue—obesity	0.00538	0.133	CbGeAlD
Conivaptan—AVPR1A—endocrine gland—obesity	0.00505	0.125	CbGeAlD
Conivaptan—AVPR1A—liver—obesity	0.00455	0.113	CbGeAlD
Conivaptan—Urine output increased—Diethylpropion—obesity	0.00385	0.0177	CcSEcCtD
Conivaptan—Atorvastatin—DPP4—obesity	0.00376	1	CrCbGaD
Conivaptan—Cardiac failure—Phentermine—obesity	0.00364	0.0168	CcSEcCtD
Conivaptan—Polyuria—Diethylpropion—obesity	0.00352	0.0162	CcSEcCtD
Conivaptan—Pollakiuria—Phendimetrazine—obesity	0.00347	0.016	CcSEcCtD
Conivaptan—Pharyngolaryngeal pain—Bupropion—obesity	0.0028	0.0129	CcSEcCtD
Conivaptan—Laryngeal pain—Bupropion—obesity	0.00277	0.0127	CcSEcCtD
Conivaptan—Pneumonia—Cimetidine—obesity	0.00228	0.0105	CcSEcCtD
Conivaptan—Insomnia—Methamphetamine—obesity	0.0022	0.0101	CcSEcCtD
Conivaptan—Insomnia—Benzphetamine—obesity	0.00212	0.00976	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Methamphetamine—obesity	0.0021	0.00966	CcSEcCtD
Conivaptan—Constipation—Methamphetamine—obesity	0.00208	0.00957	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Benzphetamine—obesity	0.00203	0.00931	CcSEcCtD
Conivaptan—Urine output increased—Orlistat—obesity	0.00202	0.00931	CcSEcCtD
Conivaptan—Insomnia—Phendimetrazine—obesity	0.00193	0.00889	CcSEcCtD
Conivaptan—Sepsis—Sibutramine—obesity	0.00188	0.00865	CcSEcCtD
Conivaptan—Erythema—Diethylpropion—obesity	0.00186	0.00857	CcSEcCtD
Conivaptan—Polyuria—Orlistat—obesity	0.00185	0.00851	CcSEcCtD
Conivaptan—Hypertension—Phentermine—obesity	0.00185	0.0085	CcSEcCtD
Conivaptan—Confusional state—Phenylpropanolamine—obesity	0.00184	0.00847	CcSEcCtD
Conivaptan—Constipation—Phendimetrazine—obesity	0.00183	0.00841	CcSEcCtD
Conivaptan—Phlebitis—Sibutramine—obesity	0.00183	0.0084	CcSEcCtD
Conivaptan—Dry mouth—Phentermine—obesity	0.00178	0.0082	CcSEcCtD
Conivaptan—Urine output increased—Bupropion—obesity	0.00171	0.00785	CcSEcCtD
Conivaptan—Thirst—Orlistat—obesity	0.00171	0.00785	CcSEcCtD
Conivaptan—Hypotension—Phenylpropanolamine—obesity	0.00171	0.00785	CcSEcCtD
Conivaptan—Hypoglycaemia—Orlistat—obesity	0.00167	0.00766	CcSEcCtD
Conivaptan—Diarrhoea—Methamphetamine—obesity	0.00166	0.00766	CcSEcCtD
Conivaptan—Atrial fibrillation—Sibutramine—obesity	0.00166	0.00763	CcSEcCtD
Conivaptan—Thirst—Sibutramine—obesity	0.00165	0.0076	CcSEcCtD
Conivaptan—Insomnia—Phenylpropanolamine—obesity	0.00165	0.0076	CcSEcCtD
Conivaptan—Hypoglycaemia—Sibutramine—obesity	0.00161	0.00741	CcSEcCtD
Conivaptan—Diarrhoea—Benzphetamine—obesity	0.00161	0.00738	CcSEcCtD
Conivaptan—Phlebitis—Bupropion—obesity	0.00159	0.00732	CcSEcCtD
Conivaptan—Insomnia—Phentermine—obesity	0.00158	0.00727	CcSEcCtD
Conivaptan—Constipation—Phenylpropanolamine—obesity	0.00156	0.00718	CcSEcCtD
Conivaptan—Polyuria—Bupropion—obesity	0.00156	0.00718	CcSEcCtD
Conivaptan—Dry mouth—Diethylpropion—obesity	0.00155	0.00713	CcSEcCtD
Conivaptan—Headache—Methamphetamine—obesity	0.00152	0.00701	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Phentermine—obesity	0.00151	0.00694	CcSEcCtD
Conivaptan—Feeling abnormal—Phenylpropanolamine—obesity	0.00151	0.00692	CcSEcCtD
Conivaptan—Constipation—Phentermine—obesity	0.00149	0.00687	CcSEcCtD
Conivaptan—Hypokalaemia—Orlistat—obesity	0.00148	0.0068	CcSEcCtD
Conivaptan—Headache—Benzphetamine—obesity	0.00147	0.00676	CcSEcCtD
Conivaptan—Diarrhoea—Phendimetrazine—obesity	0.00146	0.00673	CcSEcCtD
Conivaptan—Dehydration—Sibutramine—obesity	0.00146	0.00673	CcSEcCtD
Conivaptan—Confusional state—Cimetidine—obesity	0.00146	0.00671	CcSEcCtD
Conivaptan—Thirst—Bupropion—obesity	0.00144	0.00663	CcSEcCtD
Conivaptan—Orthostatic hypotension—Sibutramine—obesity	0.00144	0.00661	CcSEcCtD
Conivaptan—Hypokalaemia—Sibutramine—obesity	0.00143	0.00658	CcSEcCtD
Conivaptan—Hypoglycaemia—Bupropion—obesity	0.00141	0.00646	CcSEcCtD
Conivaptan—Nausea—Benzphetamine—obesity	0.00139	0.00641	CcSEcCtD
Conivaptan—Insomnia—Diethylpropion—obesity	0.00138	0.00632	CcSEcCtD
Conivaptan—Headache—Phendimetrazine—obesity	0.00134	0.00616	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Diethylpropion—obesity	0.00131	0.00604	CcSEcCtD
Conivaptan—Constipation—Diethylpropion—obesity	0.0013	0.00598	CcSEcCtD
Conivaptan—Dehydration—Bupropion—obesity	0.00128	0.00586	CcSEcCtD
Conivaptan—Nausea—Phendimetrazine—obesity	0.00127	0.00584	CcSEcCtD
Conivaptan—Pollakiuria—Sibutramine—obesity	0.00126	0.00578	CcSEcCtD
Conivaptan—Feeling abnormal—Diethylpropion—obesity	0.00125	0.00576	CcSEcCtD
Conivaptan—Infestation—Orlistat—obesity	0.00125	0.00576	CcSEcCtD
Conivaptan—Infestation NOS—Orlistat—obesity	0.00125	0.00576	CcSEcCtD
Conivaptan—Orthostatic hypotension—Bupropion—obesity	0.00125	0.00576	CcSEcCtD
Conivaptan—Constipation—Cimetidine—obesity	0.00124	0.00569	CcSEcCtD
Conivaptan—Hyperglycaemia—Sibutramine—obesity	0.00123	0.00564	CcSEcCtD
Conivaptan—Pneumonia—Sibutramine—obesity	0.00122	0.00561	CcSEcCtD
Conivaptan—Urinary tract infection—Orlistat—obesity	0.00122	0.0056	CcSEcCtD
Conivaptan—Diarrhoea—Phentermine—obesity	0.0012	0.0055	CcSEcCtD
Conivaptan—Feeling abnormal—Cimetidine—obesity	0.00119	0.00548	CcSEcCtD
Conivaptan—Urinary tract infection—Sibutramine—obesity	0.00118	0.00542	CcSEcCtD
Conivaptan—Vomiting—Phenylpropanolamine—obesity	0.00116	0.00534	CcSEcCtD
Conivaptan—Haematuria—Sibutramine—obesity	0.00116	0.00531	CcSEcCtD
Conivaptan—Candida infection—Topiramate—obesity	0.00115	0.00528	CcSEcCtD
Conivaptan—Body temperature increased—Cimetidine—obesity	0.00114	0.00526	CcSEcCtD
Conivaptan—Vomiting—Phentermine—obesity	0.00111	0.00511	CcSEcCtD
Conivaptan—Urinary tract disorder—Orlistat—obesity	0.00111	0.00511	CcSEcCtD
Conivaptan—Oedema peripheral—Orlistat—obesity	0.00111	0.00509	CcSEcCtD
Conivaptan—Urethral disorder—Orlistat—obesity	0.0011	0.00507	CcSEcCtD
Conivaptan—Headache—Phentermine—obesity	0.00109	0.00504	CcSEcCtD
Conivaptan—Pollakiuria—Bupropion—obesity	0.00109	0.00503	CcSEcCtD
Conivaptan—Urine output increased—Topiramate—obesity	0.00109	0.005	CcSEcCtD
Conivaptan—Nausea—Phenylpropanolamine—obesity	0.00108	0.00499	CcSEcCtD
Conivaptan—Oedema peripheral—Sibutramine—obesity	0.00107	0.00493	CcSEcCtD
Conivaptan—Hyperglycaemia—Bupropion—obesity	0.00107	0.00492	CcSEcCtD
Conivaptan—Pneumonia—Bupropion—obesity	0.00106	0.00489	CcSEcCtD
Conivaptan—Infestation NOS—Bupropion—obesity	0.00106	0.00486	CcSEcCtD
Conivaptan—Infestation—Bupropion—obesity	0.00106	0.00486	CcSEcCtD
Conivaptan—Diarrhoea—Diethylpropion—obesity	0.00104	0.00478	CcSEcCtD
Conivaptan—Nausea—Phentermine—obesity	0.00104	0.00477	CcSEcCtD
Conivaptan—Urinary tract infection—Bupropion—obesity	0.00103	0.00472	CcSEcCtD
Conivaptan—Phlebitis—Topiramate—obesity	0.00101	0.00466	CcSEcCtD
Conivaptan—Mediastinal disorder—Orlistat—obesity	0.00101	0.00466	CcSEcCtD
Conivaptan—Polyuria—Topiramate—obesity	0.000995	0.00458	CcSEcCtD
Conivaptan—Diarrhoea—Cimetidine—obesity	0.00099	0.00455	CcSEcCtD
Conivaptan—Angiopathy—Sibutramine—obesity	0.000987	0.00454	CcSEcCtD
Conivaptan—Mental disorder—Orlistat—obesity	0.000985	0.00453	CcSEcCtD
Conivaptan—Malnutrition—Orlistat—obesity	0.000979	0.0045	CcSEcCtD
Conivaptan—Vomiting—Diethylpropion—obesity	0.000967	0.00445	CcSEcCtD
Conivaptan—Headache—Diethylpropion—obesity	0.000953	0.00438	CcSEcCtD
Conivaptan—Malnutrition—Sibutramine—obesity	0.000947	0.00436	CcSEcCtD
Conivaptan—Urinary tract disorder—Bupropion—obesity	0.000937	0.00431	CcSEcCtD
Conivaptan—Oedema peripheral—Bupropion—obesity	0.000934	0.0043	CcSEcCtD
Conivaptan—Urethral disorder—Bupropion—obesity	0.00093	0.00428	CcSEcCtD
Conivaptan—Vomiting—Cimetidine—obesity	0.00092	0.00423	CcSEcCtD
Conivaptan—Thirst—Topiramate—obesity	0.000918	0.00422	CcSEcCtD
Conivaptan—Headache—Cimetidine—obesity	0.000906	0.00417	CcSEcCtD
Conivaptan—Nausea—Diethylpropion—obesity	0.000903	0.00415	CcSEcCtD
Conivaptan—Hypoglycaemia—Topiramate—obesity	0.000895	0.00412	CcSEcCtD
Conivaptan—Cardiac disorder—Bupropion—obesity	0.00088	0.00405	CcSEcCtD
Conivaptan—Hyponatraemia—Topiramate—obesity	0.000877	0.00403	CcSEcCtD
Conivaptan—Anaemia—Sibutramine—obesity	0.000875	0.00403	CcSEcCtD
Conivaptan—Angiopathy—Bupropion—obesity	0.000861	0.00396	CcSEcCtD
Conivaptan—Nausea—Cimetidine—obesity	0.000859	0.00395	CcSEcCtD
Conivaptan—Mediastinal disorder—Bupropion—obesity	0.000855	0.00393	CcSEcCtD
Conivaptan—Mental disorder—Bupropion—obesity	0.000831	0.00382	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000827	0.00381	CcSEcCtD
Conivaptan—Malnutrition—Bupropion—obesity	0.000826	0.0038	CcSEcCtD
Conivaptan—Hypertension—Sibutramine—obesity	0.000818	0.00376	CcSEcCtD
Conivaptan—Dry mouth—Orlistat—obesity	0.000815	0.00375	CcSEcCtD
Conivaptan—Dehydration—Topiramate—obesity	0.000812	0.00374	CcSEcCtD
Conivaptan—Orthostatic hypotension—Topiramate—obesity	0.000798	0.00367	CcSEcCtD
Conivaptan—Hypokalaemia—Topiramate—obesity	0.000795	0.00366	CcSEcCtD
Conivaptan—Infection—Orlistat—obesity	0.000794	0.00365	CcSEcCtD
Conivaptan—Dry mouth—Sibutramine—obesity	0.000789	0.00363	CcSEcCtD
Conivaptan—Nervous system disorder—Orlistat—obesity	0.000783	0.0036	CcSEcCtD
Conivaptan—Confusional state—Sibutramine—obesity	0.000779	0.00358	CcSEcCtD
Conivaptan—Skin disorder—Orlistat—obesity	0.000776	0.00357	CcSEcCtD
Conivaptan—CYP3A4—digestive system—obesity	0.000771	0.0191	CbGeAlD
Conivaptan—Infection—Sibutramine—obesity	0.000768	0.00353	CcSEcCtD
Conivaptan—Anaemia—Bupropion—obesity	0.000763	0.00351	CcSEcCtD
Conivaptan—Skin disorder—Sibutramine—obesity	0.000751	0.00345	CcSEcCtD
Conivaptan—Insomnia—Orlistat—obesity	0.000722	0.00332	CcSEcCtD
Conivaptan—Hypotension—Sibutramine—obesity	0.000722	0.00332	CcSEcCtD
Conivaptan—Hypertension—Bupropion—obesity	0.000713	0.00328	CcSEcCtD
Conivaptan—Insomnia—Sibutramine—obesity	0.000699	0.00322	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000698	0.00321	CcSEcCtD
Conivaptan—Pollakiuria—Topiramate—obesity	0.000697	0.00321	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Orlistat—obesity	0.00069	0.00317	CcSEcCtD
Conivaptan—Dry mouth—Bupropion—obesity	0.000688	0.00316	CcSEcCtD
Conivaptan—Pain—Orlistat—obesity	0.000683	0.00314	CcSEcCtD
Conivaptan—Hyperglycaemia—Topiramate—obesity	0.000681	0.00313	CcSEcCtD
Conivaptan—Confusional state—Bupropion—obesity	0.00068	0.00313	CcSEcCtD
Conivaptan—Pneumonia—Topiramate—obesity	0.000677	0.00311	CcSEcCtD
Conivaptan—Infestation NOS—Topiramate—obesity	0.000673	0.0031	CcSEcCtD
Conivaptan—Infestation—Topiramate—obesity	0.000673	0.0031	CcSEcCtD
Conivaptan—Infection—Bupropion—obesity	0.00067	0.00308	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Sibutramine—obesity	0.000667	0.00307	CcSEcCtD
Conivaptan—Pain—Sibutramine—obesity	0.000661	0.00304	CcSEcCtD
Conivaptan—Constipation—Sibutramine—obesity	0.000661	0.00304	CcSEcCtD
Conivaptan—Nervous system disorder—Bupropion—obesity	0.000661	0.00304	CcSEcCtD
Conivaptan—Feeling abnormal—Orlistat—obesity	0.000658	0.00303	CcSEcCtD
Conivaptan—Skin disorder—Bupropion—obesity	0.000655	0.00301	CcSEcCtD
Conivaptan—Urinary tract infection—Topiramate—obesity	0.000654	0.00301	CcSEcCtD
Conivaptan—Haematuria—Topiramate—obesity	0.000642	0.00295	CcSEcCtD
Conivaptan—Feeling abnormal—Sibutramine—obesity	0.000637	0.00293	CcSEcCtD
Conivaptan—CYP3A4—endocrine gland—obesity	0.000637	0.0158	CbGeAlD
Conivaptan—Body temperature increased—Orlistat—obesity	0.000631	0.0029	CcSEcCtD
Conivaptan—Hypotension—Bupropion—obesity	0.00063	0.0029	CcSEcCtD
Conivaptan—Body temperature increased—Sibutramine—obesity	0.000611	0.00281	CcSEcCtD
Conivaptan—Insomnia—Bupropion—obesity	0.00061	0.0028	CcSEcCtD
Conivaptan—Urinary tract disorder—Topiramate—obesity	0.000597	0.00274	CcSEcCtD
Conivaptan—Oedema peripheral—Topiramate—obesity	0.000595	0.00274	CcSEcCtD
Conivaptan—Urethral disorder—Topiramate—obesity	0.000592	0.00272	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Bupropion—obesity	0.000582	0.00268	CcSEcCtD
Conivaptan—Pain—Bupropion—obesity	0.000576	0.00265	CcSEcCtD
Conivaptan—Constipation—Bupropion—obesity	0.000576	0.00265	CcSEcCtD
Conivaptan—CYP3A4—liver—obesity	0.000574	0.0142	CbGeAlD
Conivaptan—Pruritus—Orlistat—obesity	0.000565	0.0026	CcSEcCtD
Conivaptan—Cardiac disorder—Topiramate—obesity	0.000561	0.00258	CcSEcCtD
Conivaptan—Feeling abnormal—Bupropion—obesity	0.000555	0.00255	CcSEcCtD
Conivaptan—Angiopathy—Topiramate—obesity	0.000548	0.00252	CcSEcCtD
Conivaptan—Pruritus—Sibutramine—obesity	0.000547	0.00252	CcSEcCtD
Conivaptan—Diarrhoea—Orlistat—obesity	0.000547	0.00251	CcSEcCtD
Conivaptan—Mediastinal disorder—Topiramate—obesity	0.000545	0.0025	CcSEcCtD
Conivaptan—Body temperature increased—Bupropion—obesity	0.000533	0.00245	CcSEcCtD
Conivaptan—Mental disorder—Topiramate—obesity	0.000529	0.00243	CcSEcCtD
Conivaptan—Diarrhoea—Sibutramine—obesity	0.000529	0.00243	CcSEcCtD
Conivaptan—Malnutrition—Topiramate—obesity	0.000526	0.00242	CcSEcCtD
Conivaptan—Erythema—Topiramate—obesity	0.000526	0.00242	CcSEcCtD
Conivaptan—Vomiting—Orlistat—obesity	0.000508	0.00234	CcSEcCtD
Conivaptan—Headache—Orlistat—obesity	0.0005	0.0023	CcSEcCtD
Conivaptan—Vomiting—Sibutramine—obesity	0.000492	0.00226	CcSEcCtD
Conivaptan—Anaemia—Topiramate—obesity	0.000486	0.00224	CcSEcCtD
Conivaptan—Headache—Sibutramine—obesity	0.000484	0.00223	CcSEcCtD
Conivaptan—Pruritus—Bupropion—obesity	0.000477	0.00219	CcSEcCtD
Conivaptan—Nausea—Orlistat—obesity	0.000474	0.00218	CcSEcCtD
Conivaptan—Diarrhoea—Bupropion—obesity	0.000461	0.00212	CcSEcCtD
Conivaptan—Nausea—Sibutramine—obesity	0.000459	0.00211	CcSEcCtD
Conivaptan—Hypertension—Topiramate—obesity	0.000454	0.00209	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000445	0.00205	CcSEcCtD
Conivaptan—Dry mouth—Topiramate—obesity	0.000438	0.00201	CcSEcCtD
Conivaptan—Confusional state—Topiramate—obesity	0.000433	0.00199	CcSEcCtD
Conivaptan—Vomiting—Bupropion—obesity	0.000428	0.00197	CcSEcCtD
Conivaptan—Infection—Topiramate—obesity	0.000427	0.00196	CcSEcCtD
Conivaptan—Headache—Bupropion—obesity	0.000422	0.00194	CcSEcCtD
Conivaptan—Nervous system disorder—Topiramate—obesity	0.000421	0.00194	CcSEcCtD
Conivaptan—Skin disorder—Topiramate—obesity	0.000417	0.00192	CcSEcCtD
Conivaptan—Hypotension—Topiramate—obesity	0.000401	0.00185	CcSEcCtD
Conivaptan—Nausea—Bupropion—obesity	0.0004	0.00184	CcSEcCtD
Conivaptan—Insomnia—Topiramate—obesity	0.000388	0.00179	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Topiramate—obesity	0.000371	0.0017	CcSEcCtD
Conivaptan—Pain—Topiramate—obesity	0.000367	0.00169	CcSEcCtD
Conivaptan—Constipation—Topiramate—obesity	0.000367	0.00169	CcSEcCtD
Conivaptan—Feeling abnormal—Topiramate—obesity	0.000354	0.00163	CcSEcCtD
Conivaptan—Body temperature increased—Topiramate—obesity	0.000339	0.00156	CcSEcCtD
Conivaptan—Pruritus—Topiramate—obesity	0.000304	0.0014	CcSEcCtD
Conivaptan—Diarrhoea—Topiramate—obesity	0.000294	0.00135	CcSEcCtD
Conivaptan—Vomiting—Topiramate—obesity	0.000273	0.00126	CcSEcCtD
Conivaptan—Headache—Topiramate—obesity	0.000269	0.00124	CcSEcCtD
Conivaptan—Nausea—Topiramate—obesity	0.000255	0.00117	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3R1—obesity	5.73e-05	0.000178	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FOXO3—obesity	5.71e-05	0.000177	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADRB2—obesity	5.69e-05	0.000176	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FOXO3—obesity	5.66e-05	0.000175	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADRB2—obesity	5.65e-05	0.000175	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SOCS1—obesity	5.6e-05	0.000174	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SOCS1—obesity	5.56e-05	0.000172	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CD—obesity	5.55e-05	0.000172	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SOCS3—obesity	5.54e-05	0.000171	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CD—obesity	5.51e-05	0.000171	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SOCS3—obesity	5.5e-05	0.00017	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—obesity	5.45e-05	0.000169	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GNB3—obesity	5.42e-05	0.000168	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP2E1—obesity	5.4e-05	0.000167	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GNB3—obesity	5.38e-05	0.000167	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—TYK2—obesity	5.34e-05	0.000166	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CB—obesity	5.33e-05	0.000165	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP2E1—obesity	5.33e-05	0.000165	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF2—obesity	5.32e-05	0.000165	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—TYK2—obesity	5.3e-05	0.000164	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—RHOA—obesity	5.3e-05	0.000164	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CB—obesity	5.29e-05	0.000164	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF2—obesity	5.28e-05	0.000164	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GNAS—obesity	5.28e-05	0.000163	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—RHOA—obesity	5.26e-05	0.000163	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3R1—obesity	5.24e-05	0.000162	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GNAS—obesity	5.24e-05	0.000162	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3R1—obesity	5.21e-05	0.000161	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOB—obesity	5.17e-05	0.00016	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOB—obesity	5.13e-05	0.000159	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL5—obesity	5.05e-05	0.000156	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL5—obesity	5.01e-05	0.000155	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GGT1—obesity	4.96e-05	0.000154	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LPL—obesity	4.93e-05	0.000153	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FOXO1—obesity	4.9e-05	0.000152	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LPL—obesity	4.9e-05	0.000152	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RPS6KB1—obesity	4.89e-05	0.000151	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—NCOA1—obesity	4.89e-05	0.000151	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FOXO1—obesity	4.86e-05	0.000151	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RPS6KB1—obesity	4.85e-05	0.00015	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CB—obesity	4.84e-05	0.00015	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP19A1—obesity	4.82e-05	0.000149	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CB—obesity	4.81e-05	0.000149	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP19A1—obesity	4.75e-05	0.000147	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRKCD—obesity	4.55e-05	0.000141	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRKCD—obesity	4.51e-05	0.00014	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CA3—obesity	4.51e-05	0.00014	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—COMT—obesity	4.48e-05	0.000139	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR2A—obesity	4.45e-05	0.000138	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—C3—obesity	4.44e-05	0.000138	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—COMT—obesity	4.42e-05	0.000137	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR2A—obesity	4.42e-05	0.000137	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—C3—obesity	4.41e-05	0.000137	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IRS2—obesity	4.23e-05	0.000131	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AGT—obesity	4.22e-05	0.000131	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IRS2—obesity	4.2e-05	0.00013	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AGT—obesity	4.19e-05	0.00013	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOE—obesity	4.14e-05	0.000128	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LEP—obesity	4.14e-05	0.000128	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOE—obesity	4.11e-05	0.000127	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LEP—obesity	4.11e-05	0.000127	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CAV1—obesity	4.1e-05	0.000127	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOA1—obesity	4.09e-05	0.000127	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CAV1—obesity	4.07e-05	0.000126	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOA1—obesity	4.06e-05	0.000126	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ESR1—obesity	3.95e-05	0.000122	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ESR1—obesity	3.92e-05	0.000121	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—F2—obesity	3.9e-05	0.000121	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRKCB—obesity	3.9e-05	0.000121	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—F2—obesity	3.87e-05	0.00012	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRKCB—obesity	3.87e-05	0.00012	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—BAD—obesity	3.85e-05	0.000119	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GLRX—obesity	3.83e-05	0.000119	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—BAD—obesity	3.83e-05	0.000119	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CG—obesity	3.73e-05	0.000116	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CG—obesity	3.71e-05	0.000115	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IRS1—obesity	3.69e-05	0.000114	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IRS1—obesity	3.66e-05	0.000113	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—POMC—obesity	3.55e-05	0.00011	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—INS—obesity	3.53e-05	0.000109	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—POMC—obesity	3.53e-05	0.000109	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—INS—obesity	3.51e-05	0.000109	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL2—obesity	3.48e-05	0.000108	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL2—obesity	3.45e-05	0.000107	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF1—obesity	3.42e-05	0.000106	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ETFDH—obesity	3.42e-05	0.000106	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—OTC—obesity	3.42e-05	0.000106	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPM1L—obesity	3.42e-05	0.000106	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—INSIG2—obesity	3.42e-05	0.000106	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT2—obesity	3.41e-05	0.000106	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF1—obesity	3.39e-05	0.000105	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT2—obesity	3.39e-05	0.000105	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CD—obesity	3.28e-05	0.000102	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CD—obesity	3.26e-05	0.000101	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CA—obesity	3.25e-05	0.000101	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SERPINE1—obesity	3.25e-05	0.000101	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CA—obesity	3.23e-05	0.0001	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SERPINE1—obesity	3.22e-05	9.98e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TYK2—obesity	3.16e-05	9.78e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TYK2—obesity	3.13e-05	9.71e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RHOA—obesity	3.13e-05	9.7e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—INPP5E—obesity	3.12e-05	9.68e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPT—obesity	3.12e-05	9.68e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—UQCRC2—obesity	3.12e-05	9.68e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RHOA—obesity	3.11e-05	9.63e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3R1—obesity	3.1e-05	9.6e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOS3—obesity	3.1e-05	9.6e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOS3—obesity	3.08e-05	9.53e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3R1—obesity	3.08e-05	9.53e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CA—obesity	2.95e-05	9.14e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CA—obesity	2.93e-05	9.08e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDH6A1—obesity	2.9e-05	9e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ME1—obesity	2.9e-05	9e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SUCLG2—obesity	2.9e-05	9e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—POMC—obesity	2.89e-05	8.97e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CB—obesity	2.86e-05	8.86e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MTOR—obesity	2.86e-05	8.86e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CB—obesity	2.84e-05	8.8e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MTOR—obesity	2.84e-05	8.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—COX7C—obesity	2.73e-05	8.46e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—UCP1—obesity	2.73e-05	8.46e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PNPLA3—obesity	2.73e-05	8.46e-05	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AKT1—obesity	2.65e-05	8.22e-05	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AKT1—obesity	2.64e-05	8.17e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—obesity	2.61e-05	8.1e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—obesity	2.59e-05	8.04e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CS—obesity	2.59e-05	8.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DGAT2—obesity	2.59e-05	8.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SUCLA2—obesity	2.59e-05	8.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CPS1—obesity	2.59e-05	8.02e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP9—obesity	2.49e-05	7.7e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MUT—obesity	2.47e-05	7.65e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LIPE—obesity	2.47e-05	7.65e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP9—obesity	2.47e-05	7.65e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK8—obesity	2.42e-05	7.49e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AKT1—obesity	2.41e-05	7.47e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK8—obesity	2.4e-05	7.44e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AKT1—obesity	2.39e-05	7.42e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DGAT1—obesity	2.37e-05	7.33e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYB5A—obesity	2.37e-05	7.33e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ACLY—obesity	2.28e-05	7.06e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—STAT3—obesity	2.21e-05	6.85e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ENPP1—obesity	2.2e-05	6.82e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALOX12—obesity	2.2e-05	6.82e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—STAT3—obesity	2.19e-05	6.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMGCS1—obesity	2.13e-05	6.6e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PFKFB3—obesity	2.07e-05	6.41e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ACADM—obesity	2.07e-05	6.41e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ANGPTL4—obesity	2.07e-05	6.41e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PNPLA2—obesity	2.07e-05	6.41e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLIN1—obesity	2.07e-05	6.41e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SAT1—obesity	2.07e-05	6.41e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MYC—obesity	2.05e-05	6.36e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFB1—obesity	2.05e-05	6.35e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MYC—obesity	2.04e-05	6.32e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFB1—obesity	2.03e-05	6.3e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—OXCT1—obesity	2.01e-05	6.24e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ACACB—obesity	2.01e-05	6.24e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYTB—obesity	2.01e-05	6.24e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PNLIP—obesity	1.96e-05	6.08e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SRD5A1—obesity	1.96e-05	6.08e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SDC3—obesity	1.91e-05	5.93e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP26B1—obesity	1.87e-05	5.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HK2—obesity	1.87e-05	5.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—STS—obesity	1.87e-05	5.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARD—obesity	1.83e-05	5.67e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC27A1—obesity	1.79e-05	5.56e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GLUL—obesity	1.76e-05	5.45e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FABP4—obesity	1.76e-05	5.45e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CA—obesity	1.74e-05	5.4e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CA—obesity	1.73e-05	5.36e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—UCP3—obesity	1.67e-05	5.17e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HSD11B1—obesity	1.67e-05	5.17e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—UCP2—obesity	1.67e-05	5.17e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ECHS1—obesity	1.67e-05	5.17e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADH1B—obesity	1.64e-05	5.08e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ACSL1—obesity	1.62e-05	5e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARGC1B—obesity	1.62e-05	5e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPAM—obesity	1.62e-05	5e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FADS1—obesity	1.57e-05	4.86e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PCK1—obesity	1.57e-05	4.86e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HADH—obesity	1.57e-05	4.86e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—obesity	1.54e-05	4.78e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—obesity	1.53e-05	4.75e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ACP5—obesity	1.53e-05	4.73e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—G6PD—obesity	1.49e-05	4.61e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SREBF2—obesity	1.47e-05	4.55e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HK1—obesity	1.47e-05	4.55e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT1—obesity	1.42e-05	4.41e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPA—obesity	1.42e-05	4.39e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT1—obesity	1.41e-05	4.38e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPIN1—obesity	1.39e-05	4.3e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA5—obesity	1.36e-05	4.21e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CLOCK—obesity	1.3e-05	4.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC22A1—obesity	1.3e-05	4.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SULT2A1—obesity	1.26e-05	3.92e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GLP1R—obesity	1.26e-05	3.92e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DPYD—obesity	1.24e-05	3.85e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PRKAR2B—obesity	1.2e-05	3.71e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DCN—obesity	1.19e-05	3.68e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CPT1A—obesity	1.16e-05	3.58e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NAMPT—obesity	1.13e-05	3.51e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LIPC—obesity	1.13e-05	3.49e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GCK—obesity	1.13e-05	3.49e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOC3—obesity	1.12e-05	3.47e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CETP—obesity	1.09e-05	3.37e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SDC1—obesity	1.07e-05	3.33e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKR1C3—obesity	1.06e-05	3.28e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SCARB1—obesity	1.04e-05	3.22e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SREBF1—obesity	1.01e-05	3.13e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GOT2—obesity	9.83e-06	3.05e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FASN—obesity	9.62e-06	2.98e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—BCHE—obesity	9.58e-06	2.97e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2E1—obesity	9.24e-06	2.86e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NQO1—obesity	9.14e-06	2.83e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GCG—obesity	8.76e-06	2.71e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC2A4—obesity	8.76e-06	2.71e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYCS—obesity	8.65e-06	2.68e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GOT1—obesity	8.49e-06	2.63e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GGT1—obesity	8.49e-06	2.63e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NCOA1—obesity	8.36e-06	2.59e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—STK11—obesity	8.24e-06	2.55e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP19A1—obesity	8.24e-06	2.55e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—COMT—obesity	7.66e-06	2.37e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GNB3—obesity	7.55e-06	2.34e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARGC1A—obesity	7.55e-06	2.34e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMOX1—obesity	7.52e-06	2.33e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GNAS—obesity	7.35e-06	2.28e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOB—obesity	7.2e-06	2.23e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPL—obesity	6.88e-06	2.13e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPX1—obesity	6.71e-06	2.08e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CD36—obesity	6.53e-06	2.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTHFR—obesity	6.19e-06	1.92e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARA—obesity	6.07e-06	1.88e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AGT—obesity	5.88e-06	1.82e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOE—obesity	5.76e-06	1.79e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CAV1—obesity	5.71e-06	1.77e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA1—obesity	5.7e-06	1.76e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CG—obesity	5.2e-06	1.61e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARG—obesity	5.02e-06	1.56e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—POMC—obesity	4.95e-06	1.53e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—INS—obesity	4.92e-06	1.53e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CD—obesity	4.57e-06	1.42e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALB—obesity	4.51e-06	1.4e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3R1—obesity	4.32e-06	1.34e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NOS3—obesity	4.32e-06	1.34e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CB—obesity	3.99e-06	1.23e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—obesity	3.95e-06	1.22e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CA—obesity	2.43e-06	7.53e-06	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKT1—obesity	1.98e-06	6.15e-06	CbGpPWpGaD
